logo
Select company
Select metric
-73.24%Return on Equity
VS
Market
15
Sector
39
Industry
49
History
-
$ 3.3Close
$ 1.72 - $ 8.5 52-Week Range
Ticker Information

Ticker

MRVI

Company Name

MARAVAI LIFESCIENCES HOLDINGS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

MARAVAI LIFESCIENCES HOLDINGS INC - Return on Equity Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

MRVI - ROE Historical data
DateShareholders EquityNet Income Common StockReturn on Equity
6/30/2025$ 265.86M$ -194.72M-73.24%
3/31/2025$ 300.61M$ -162.71M-54.13%
12/31/2024$ 325.29M$ -144.85M-44.53%
9/30/2024$ 345.14M$ -224.66M-65.09%
6/30/2024$ 436.93M$ -132.08M-30.23%
3/31/2024$ 410.66M$ -131.04M-31.91%
12/31/2023$ 416.75M$ -119.03M-28.56%
9/30/2023$ 519.29M$ 24.56M4.73%
6/30/2023$ 520.57M$ 75.5M14.5%
3/31/2023$ 521.52M$ 153.28M29.39%
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • MARAVAI LIFESCIENCES HOLDINGS INC's latest trailing twelve months (TTM) ROE stands at -3.16%.
  • Over the past 5 years, MARAVAI LIFESCIENCES HOLDINGS INC's average ROE has been 7.06%.
  • The median ROE for MARAVAI LIFESCIENCES HOLDINGS INC during this period was 9.62%
  • MARAVAI LIFESCIENCES HOLDINGS INC reached its highest ROE over the past 5 years at 100.52%.
  • The lowest ROE recorded by MARAVAI LIFESCIENCES HOLDINGS INC in the same timeframe -73.24%

MARAVAI LIFESCIENCES HOLDINGS INC's ROE vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

ROE Benchmarks
CompanyROE
KROS : KEROS THERAPEUTICS INC 2.66%XNCR : XENCOR INC -27.58%RIGL : RIGEL PHARMACEUTICALS INC 119.39%DAWN : DAY ONE BIOPHARMACEUTICALS INC -20.61%STOK : STOKE THERAPEUTICS INC 15.67%RGNX : REGENXBIO INC -82.17%AKBA : AKEBIA THERAPEUTICS INC -124.84%VNDA : VANDA PHARMACEUTICALS INC -13.76%DNA : GINKGO BIOWORKS HOLDINGS INC -51.42%ANAB : ANAPTYSBIO INC -

Definition of Return on Equity

[Calculation] Return on Equity (ROE) measures net income [NetIncCmn] as percentage of [Equity]. A high ROE shows an effective use of investor capital, but it doesn't consider any risks related to financial leverage [Debt].
Net Inc. Cmn. / Equity
(=) ROE
ROE for MARAVAI LIFESCIENCES HOLDINGS INC is calculated as follows: Net Inc. Cmn. [ $ -4.47M ] / Equity [ $ 141.4M ]
(=) ROE [ -3.16% ]

MRVI - Return on Equity, Last 5 years

-73.24%

Minimum

Jun 30, 2025

100.52%

Maximum

Dec 31, 2020

7.06%

Average

9.62%

Median

ROE Benchmark Analysis

The chart above depicts the distribution of ROE for companies in the Total Stock Market. The average ROE of the companies is 1.51% with a standard deviation of 22.67%.
The following table provides additional summary stats:
ROE in the Market:
filtered constituents3.14K
min-66.79%
max73.25%
average1.51%
median6.45%
std22.67%